The new Ryzen AI Max+ "Strix Halo" chips include the Ryzen AI Max+ 392 and Ryzen AI Max+ 388. Both feature boost speeds up to ...

Tempus AI, Inc. (NASDAQ:TEM) is one of the best healthcare AI stocks to buy now. On December 15, JPMorgan lowered its price target on Tempus AI, Inc. (NASDAQ:TEM) from $85 to $80. The firm maintained ...

Tempus AI (TEM) has cooled off after a huge run this year, with the stock slipping about 18% in the past month and 16% over the past 3 months from its recent highs. See our latest analysis for Tempus ...

In trading on Wednesday, shares of Tempus AI Inc (Symbol: TEM) crossed below their 200 day moving average of $67.03, changing hands as low as $66.66 per share. Tempus AI Inc shares are currently ...

Tempus AI remains a Buy after a market-driven correction, with operational performance and partnerships strengthening the long-term thesis. TEM's organic revenue grew 28% y/y, gross margins improved ...

Fintel reports that on December 22, 2025, Canaccord Genuity maintained coverage of Tempus AI (NasdaqGS:TEM) with a Buy recommendation. Analyst Price Forecast Suggests 40.19% Upside As of December 21, ...

Tempus AI is rated a strong buy for risk-tolerant investors, leveraging its vast proprietary healthcare data to drive precision medicine via AI and ML. TEM delivered 85% YoY revenue growth in Q3 2025, ...

Tempus AI TEM is transitioning from a heavy-investment growth stage toward improved operating leverage and a more scalable mix of revenue. This is possible as the company integrates genomics, ...

GameSpot may get a commission from retail offers. Baldur's Gate 3 and Divinity developer Larian has confirmed that it uses generative AI in its development processes, but not necessarily in the way ...